Following the receipt of updated shares in issue information from Merck & Co. Inc. (USA, Constituent), resulting in a market capitalisation change greater than USD 2bn, FTSE announces the following changes: | INDEX | CHANGE | EFFECTIVE FROM
START OF TRADING | | FTSE All-World Index | Merck & Co. Inc. (USA, 2778844) will remain in the index with an increased shares in issue total of 3,115,317,260 and an unchanged investability weighting of 100%. | 22 March 2010 | | FTSE Multinationals | Merck & Co will remain in the index as detailed above. | 22 March 2010 | | FTSE Global 100 | Merck & Co will remain in the index as detailed above. | 22 March 2010 | | FTSE Global Sector - Pharmaceuticals | Merck & Co will remain in the index as detailed above. | 22 March 2010 | | FTSE Global Style Index | Merck & Co Group will remain in the index as detailed above. | 22 March 2010 | | FTSE4Good Global Index | Merck & Co Group will remain in the index as detailed above. | 22 March 2010 | | FTSE4Good Global 100 Index | Merck & Co Group will remain in the index as detailed above. | 22 March 2010 | | FTSE4Good USA Index | Merck & Co Group will remain in the index as detailed above. | 22 March 2010 | | FTSE4Good USA 100 Index | Merck & Co Group will remain in the index as detailed above. | 22 March 2010 |
FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients. For further information or general enquiries please contact us at info@ftse.com or call: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in Europe, Middle East & Africa: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139 | | Client Services in Asia Pacific: | Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811 |
Alternatively please visit our website at www.ftse.com |
